Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

13,714 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 13,714 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Testing effectiveness (Phase 2)Looking for participantsNCT06178159
What this trial is testing

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
RemeGen Co., Ltd. 40
Not applicableUnknownNCT00114296
What this trial is testing

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 80
Testing effectiveness (Phase 2)WithdrawnNCT01933061
What this trial is testing

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Celgene Corporation
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)UnknownNCT01635686
What this trial is testing

Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

Who this might be right for
Rheumatoid Arthritis
Daewoong Pharmaceutical Co. LTD. 38
Not applicableStudy completedNCT03949270
What this trial is testing

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

Who this might be right for
Breast CancerAdherence, MedicationSide Effect
Yale University 400
Post-approval studies (Phase 4)Study completedNCT06210594
What this trial is testing

Staph Intervention for Effective Local Defense

Who this might be right for
Staphylococcus Aureus Infection
Johns Hopkins Bloomberg School of Public Health 78
Early research (Phase 1)Study completedNCT00687622
What this trial is testing

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

Who this might be right for
Solid Tumours
GlaxoSmithKline 206
Large-scale testing (Phase 3)Looking for participantsNCT03417622
What this trial is testing

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Who this might be right for
Breast Cancer
Mansoura University 370
Not applicableNot Yet RecruitingNCT06827522
What this trial is testing

The Effect of Skin-to-skin Contact Between Mother and Newborn

Who this might be right for
Galvanic Skin ResponseSkin to Skin Contact
TC Erciyes University 100
Early research (Phase 1)Study completedNCT07300202
What this trial is testing

CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]

Who this might be right for
Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult VolunteersBreast Cancer
Oriplantee Company Limited 15
Large-scale testing (Phase 3)Study completedNCT02584959
What this trial is testing

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 75
Post-approval studies (Phase 4)UnknownNCT05148169
What this trial is testing

A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Shanghai Mental Health Center 150
Not applicableStudy completedNCT05771454
What this trial is testing

Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives

Who this might be right for
Genetic PredispositionBRCA MutationBreast Cancer+1 more
Aga Khan University Hospital, Pakistan 26
Not applicableLooking for participantsNCT06751056
What this trial is testing

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Who this might be right for
Pruritus
Mayo Clinic 12
Post-approval studies (Phase 4)Study completedNCT05700422
What this trial is testing

Nasal Spray Study in Sjogren's Dry Eye Disease

Who this might be right for
Sjogren's SyndromeDry Eye
University of Pennsylvania 39
Not applicableLooking for participantsNCT04638751
What this trial is testing

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Who this might be right for
Non-small Cell Lung CancerColorectal CancerTriple Negative Breast Cancer+1 more
Persephone Biosciences 5,000
Large-scale testing (Phase 3)Study completedNCT05795153
What this trial is testing

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 144
Post-approval studies (Phase 4)Study completedNCT00502853
What this trial is testing

A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 10
Load More Results